Work

A phase I study of temsirolimus (TEM) and bryostatin (BRYO) in patients with metastatic renal cell carcinoma (RCC)

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.5111

Authors: E. R. Plimack, Y. Wong, M. Von Mehren, L. Malizzia, S. K. Roethke, T. Li, S. Litwin, G. R. Hudes, N. B. Haas

Institutions: Fox Chase Cancer Center, University of Pennsylvania

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2598850404

Cites:

Cited by: 3

Related to: 10